本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Tyra Biosciences, Inc.

15.84
+0.16001.02%
盘后15.840.00000.00%16:31 EDT
成交量:15.70万
成交额:248.14万
市值:8.44亿
市盈率:-8.86
高:16.05
开:15.57
低:15.13
收:15.68
52周最高:17.78
52周最低:6.42
股本:5,329.71万
流通股本:1,721.90万
量比:0.50
换手率:0.91%
股息:- -
股息率:- -
每股收益(TTM):-1.7873
每股收益(LYR):-1.5114
净资产收益率:-31.21%
总资产收益率:-21.29%
市净率:2.79
市盈率(LYR):-10.48

数据加载中...

2024/12/06

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/19

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/10/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/28

重要事件披露

Form 8-K - Current report
2024/10/25

重要事件披露

Form 8-K - Current report
2024/10/22

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/22

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/18

重要事件披露

Form 8-K - Current report
2024/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities